AEON Biopharma Inc
AEON.WS
AEON.WS was delisted on the 26th of April, 2024.
48 hedge funds and large institutions have $7.84M invested in AEON Biopharma Inc in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
23% more funds holding
Funds holding: 39 → 48 (+9)
18% more capital invested
Capital invested by funds: $6.66M → $7.84M (+$1.18M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$342K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$199K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$120K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$119K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$87.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$204K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$4.39K |
| 3 |
CAC
Cowen and Company
New York
|
-$3.09K |
AEON.WS Hedge Fund Activity: Q3 2021 in Review
48 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q3 2021, worth a combined $7.84M — up 18% from $6.66M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AEON.WS positions and 2 closed out — a net gain of 9 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Empyrean Capital Partners, opening a new position worth an estimated $342K. The largest seller was Linden Advisors, exiting entirely with an estimated $204K sold.
- 48 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q3 2021, up from 39 in Q2 2021.
- Funds reported $7.84M of AEON Biopharma Inc stock for Q3 2021, up 18% quarter-over-quarter.
- 11 funds opened new AEON Biopharma Inc positions in Q3 2021 and 2 closed out, a net change of +9 holders.
- The largest AEON Biopharma Inc buyer in Q3 2021 was Empyrean Capital Partners, an estimated $342K added.
- The largest AEON Biopharma Inc seller in Q3 2021 was Linden Advisors, an estimated $204K sold.
Based on aggregated 13F filings for Q3 2021.